Highlander Capital Management’s EnteroMedics Inc. ETRM Stock Holding History

Highlander Capital Management’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-23	Closed	–	–	815
2016 Q4	$0	Buy	+23	New	+$121	﹤0.01%	816
2016 Q3	–	Sell	-24	Closed	–	–	823
2016 Q2	$0	Hold	24	–	–	﹤0.01%	831
2016 Q1	$2K	Sell	24 -79	-77%	-$6.38K	﹤0.01%	763
2015 Q4	$14K	Sell	103 -40	-28%	-$8.29K	0.01%	595
2015 Q3	$39K	Buy	143 +29	+25%	+$9.26K	0.04%	408
2015 Q2	$74K	Buy	114 +24	+27%	+$27.6K	0.07%	302
2015 Q1	$87K	Sell	90 -5	-5%	-$6.03K	0.08%	277
2014 Q4	$142K	Hold	95	–	–	0.12%	193
2014 Q3	$123K	Hold	95	–	–	0.12%	196
2014 Q2	$156K	Buy	+95	New	+$178K	0.14%	169

Other funds holding ETRM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Highlander Capital Management's ETRM Position: Q1 2017 in Review

Highlander Capital Management sold out of EnteroMedics Inc. (ETRM) in Q1 2017, closing a stake of 23 shares.

Highlander Capital Management first reported a position in ETRM in Q2 2014 and held it in 10 quarters. The position peaked at $156K in Q2 2014. 26 funds tracked by Wall St. Rank hold ETRM as of Q1 2017.

Highlander Capital Management reported no remaining EnteroMedics Inc. position as of Q1 2017 after selling out during the quarter.
Highlander Capital Management sold 23 EnteroMedics Inc. shares in Q1 2017.
Highlander Capital Management first reported a position in EnteroMedics Inc. in Q2 2014 and held it in 10 quarters.
Highlander Capital Management's EnteroMedics Inc. position peaked at $156K in Q2 2014.
26 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2017.

Based on Highlander Capital Management's 13F filing for Q1 2017, filed 15 May 2017.